Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Canntab Therapeutics Ltd CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and... see more

PINL:CTABF - Post Discussion

Canntab Therapeutics Ltd > Aurora starts making gel capsules
View:
Post by chillywilly123 on Aug 22, 2018 7:03pm

Aurora starts making gel capsules

Cannatab is too far behind.
Comment by canaken1 on Aug 22, 2018 9:05pm
Chilly, in what may I ask ? Oil filled capsules have been available to the market for months with different viscosity levels. However, Canntab has a patent pending formulation which is in the form of a slow THC release tablet, designated the Xtablet. Patients injest this tablet orally like any other hard Pill that doctors prescribe and one can buy from a pharmacy. Hence Canntab's trading ...more  
Comment by canaken1 on Sep 18, 2018 11:02am
nr from emblem. Development of slow release tablets was successful over a period of 12 hours. Manufacturing of the product will begin in batches for clinical testing. glta
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities